Your browser doesn't support javascript.
loading
Activity of venetoclax-based therapy in chronic myelomonocytic leukemia.
Montalban-Bravo, Guillermo; Hammond, Danielle; DiNardo, Courtney D; Konopleva, Marina; Borthakur, Gautam; Short, Nicholas J; Ramos-Perez, Jorge; Guerra, Veronica; Kanagal-Shamanna, Rashmi; Naqvi, Kiran; Sasaki, Koji; Jabbour, Elias; Pemmaraju, Naveen; Kadia, Tapan M; Ravandi, Farhad; Daver, Naval; Estrov, Zeev; Pierce, Sherry; Kantarjian, Hagop; Garcia-Manero, Guillermo.
Affiliation
  • Montalban-Bravo G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. gmontalban1@mdanderson.org.
  • Hammond D; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • DiNardo CD; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Konopleva M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Borthakur G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Short NJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ramos-Perez J; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Guerra V; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kanagal-Shamanna R; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Naqvi K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sasaki K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pemmaraju N; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kadia TM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ravandi F; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daver N; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Estrov Z; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pierce S; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia ; 35(5): 1494-1499, 2021 05.
Article in En | MEDLINE | ID: mdl-33846541
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Leukemia, Myelomonocytic, Chronic / Bridged Bicyclo Compounds, Heterocyclic / Antineoplastic Agents Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Leukemia, Myelomonocytic, Chronic / Bridged Bicyclo Compounds, Heterocyclic / Antineoplastic Agents Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: